Search Results - "Parry, Nigel R."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    Development of Cell-Based Assays for In Vitro Characterization of Hepatitis C Virus NS3/4A Protease Inhibitors by Chung, Victoria, Carroll, Anthony R, Gray, Norman M, Parry, Nigel R, Thommes, Pia A, Viner, K Claire, D'Souza, Eric A

    Published in Antimicrobial Agents and Chemotherapy (01-04-2005)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Rapid in vitro Selection of Human Immunodeficiency Virus Type 1 Resistant to 3'-Thiacytidine Inhibitors Due to a Mutation in the YMDD Region of Reverse Transcriptase by Tisdale, Margaret, Kemp, Sharon D., Parry, Nigel R., Larder, Brendan A.

    “…Resistant variants of human immunodeficiency virus type 1 (HIV-1) have been selected by limited passage in MT4 cells of both wild-type and…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 Urea Leads to Potent Intracellular Inhibitors of Hepatitis C Virus NS3/4A Protease by Slater, Martin J, Amphlett, Elizabeth M, Andrews, David M, Bamborough, Paul, Carey, Seb J, Johnson, Martin R, Jones, Paul S, Mills, Gail, Parry, Nigel R, Stewart, Alan J, Skarzynski, Tadeusz

    Published in Organic letters (27-11-2003)
    “…In this, the first of two Letters, we describe how a P3/P4 urea linking unit was used to greatly enhance the biochemical and replicon potency of inhibitors…”
    Get full text
    Journal Article
  7. 7

    1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity by DALUGE, S. M, GOOD, S. S, AVERETT, D. R, KRENITSKY, T. A, FALETTO, M. B, MILLER, W. H, CLAIR, M. H. S, BOONE, L. R, TISDALE, M, PARRY, N. R, REARDON, J. E, DORNSIFE, R. E

    Published in Antimicrobial Agents and Chemotherapy (01-05-1997)
    “…Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
    Get full text
    Journal Article
  8. 8

    Regression of Canine Oral Papillomas Is Associated with Infiltration of CD4+ and CD8+ Lymphocytes by Nicholls, Philip K., Moore, Peter F., Anderson, Davina M., Moore, Richard A., Parry, Nigel R., Gough, Gerald W., Stanley, Margaret A.

    Published in Virology (New York, N.Y.) (25-04-2001)
    “…Canine oral papillomavirus (COPV) infection is used in vaccine development against mucosal papillomaviruses. The predictable, spontaneous regression of the…”
    Get full text
    Journal Article
  9. 9

    Naturally Occurring, Nonregressing Canine Oral Papillomavirus Infection: Host Immunity, Virus Characterization, and Experimental Infection by Nicholls, Philip K., Klaunberg, Brenda A., Moore, Richard A., Santos, Elmer B., Parry, Nigel R., Gough, Gerald W., Stanley, Margaret A.

    Published in Virology (New York, N.Y.) (20-12-1999)
    “…Papillomaviruses occasionally cause severe, nonregressing or recurrent infections in their human and animal hosts. The mechanisms underlying these atypical…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2 by Tormo, J., Blaas, D., Parry, N.R., Rowlands, D., Stuart, D., Fita, I.

    Published in The EMBO journal (15-05-1994)
    “…The three‐dimensional structure of the complex between the Fab fragment of an anti‐human rhinovirus neutralizing antibody (8F5) and a cross‐reactive synthetic…”
    Get full text
    Journal Article
  12. 12

    cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid) by Fox, G, Parry, N.R, Barnett, P.V, McGinn, B, Rowlands, D.J, Brown, F

    Published in Journal of general virology (01-03-1989)
    “…1 Wellcome Biotechnology Ltd, Ash Road, Pirbright, Surrey GU24 0NQ and 2 Wellcome Biotechnology Ltd, Langley Court, Beckenham, Kent BR3 3BS, U.K. The amino…”
    Get full text
    Journal Article
  13. 13

    Synthesis and antiviral activity of acyclovir-5'-(phenyl methoxy alaninyl) phosphate as a possible membrane-soluble nucleotide prodrug by MCGUIGAN, C, SLATER, M. J, PARRY, N. R, PERRY, A, HARRIS, S

    Published in Bioorganic & medicinal chemistry letters (03-04-2000)
    “…We describe a synthesis of acyclovir-5'-(phenyl methoxy alaninyl) phosphate (2) from acyclovir (1). This compound was designed to act as a lipophilic,…”
    Get full text
    Journal Article
  14. 14

    Rescue, expression, and analysis of a neutralizing human anti-hepatitis A virus monoclonal antibody by Lewis, AP, Lemon, SM, Barber, KA, Murphy, P, Parry, NR, Peakman, TC, Sims, MJ, Worden, J, Crowe, JS

    Published in The Journal of immunology (1950) (01-09-1993)
    “…A human anti-hepatitis A virus mAb was rescued from a hybridoma cell line by conventional cDNA cloning, and expressed in CHO cells. The full nucleotide…”
    Get full text
    Journal Article